HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trialsDaniel I. Swerdlow, Rudi G. J. Westendorp, P. Johnson et al.|The Lancet|2014Cited by 709
Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant dataMichael V. Holmes, Philippa J. Talmud, Caroline Dale et al.|BMJ|2014Cited by 677
PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation studyAmand F. Schmidt, Andrzej Pająk, Daniel I. Swerdlow et al.|The Lancet Diabetes & Endocrinology|2016Cited by 390
Interleukin-6 receptor pathways in abdominal aortic aneurysmSeamus C. Harrison, Steve E. Humphries, Andrew J. Smith et al.|European Heart Journal|2012Cited by 182